Multinational pharmaceutical companies are crying foul over the illegal import of innovator drugs worth crores of rupees into the Indian market from neighboring countries and sold by pharmacies, distributors and websites. The Organization of Pharmaceutical Producers of India, which represents Abbott, Pfizer, Novartis, Novo Nordisk, GSK, Bayer, Merck and Sanofi, among others, claims the rampant and unchecked import of innovator drugs was adversely affecting the revenue of India as well as the companies. It’s not clear if these drugs were originally produced for domestic consumption in those countries and were crossing the borders. Some least developed countries including Bangladesh are allowed to produce patented drugs of innovator companies for domestic consumption. The Organization of Pharmaceutical Producers of India claims import of innovator drugs was affecting the revenue of India as well as the companies.

(Economic Times)